Clinical update

New drug available for head and neck cancer patients not responding to chemotherapy

The National Institute for Health and Care Excellence recommends nivolumab is made available for head and neck cancer that has progressed following chemotherapy.
Posted 24 November 2017 - 09:30
 
Jobs

5 Most Read Articles

Challenges and opportunities for cancer nurses in implementing digital health...

Why you should read this article: • To learn about digital health technologies that are...
24 Apr 2024

What every nurse in the NHS needs to know about the pension scheme overhaul

How you might be affected – plus a warning to anyone thinking of opting out
02 Apr 2024

Groundbreaking safe staffing law now in force for nurses in Scotland

All Scottish health and care settings must have enough qualified nurses to provide safe care
02 Apr 2024

NMC closes temporary register set up during COVID-19 crisis

Temporary register saw thousands return to nursing to aid vulnerable at peak of pandemic
01 Apr 2024

The (quiet) steps you can take to help inpatients get a good night’s sleep

Find out about measures that minimise disturbance at night – but don’t mean extra workload
01 Apr 2024
Journals
Other RCNi websites